Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis

scientific article published on January 2002

Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1017173501
P356DOI10.1038/SJ.BMT.1703324
P698PubMed publication ID11840150
P5875ResearchGate publication ID11521124

P2093author name stringCohen B
Rodriguez J
Burt RK
Oyama Y
Traynor A
Brush M
P2860cites workExtended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study GroupQ28265868
Cause of death in patients attending multiple sclerosis clinicsQ28288701
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study GroupQ28293763
Stem cell transplantation in experimental models of autoimmune diseaseQ33911440
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaQ34064209
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantationQ34170816
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study GroupQ34730962
Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacyQ40621963
An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell doseQ40624714
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.Q40625080
Major morbidity related to hyperthermia in multiple sclerosisQ40837428
Fever and evoked potentials in multiple sclerosisQ40848968
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoringQ46214595
Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitisQ46450850
Bone marrow transplantation in multiple sclerosisQ57912389
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisQ57912405
Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot studyQ58041660
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeQ59649521
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study GroupQ70650973
Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administrationQ73446036
Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancerQ77366227
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmultiple sclerosisQ8277
P304page(s)81-85
P577publication date2002-01-01
P1433published inBone Marrow TransplantationQ4941523
P1476titleEngraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis
P478volume29

Reverse relations

cites work (P2860)
Q44971633A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma
Q35994389Autologous haematopoietic-stem-cell transplantation for multiple sclerosis
Q53538901Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
Q39222708Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults
Q43198285Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center
Q38315390Engraftment syndrome: double-edged sword of hematopoietic cell transplants
Q36020897Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation
Q35870515Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective
Q37778984Hematopoietic SCT for the treatment of multiple sclerosis
Q88506851Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
Q43730168Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer.
Q104064700Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation
Q40517545Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection
Q94671653The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
Q35106133The promise of hematopoietic stem cell transplantation for autoimmune diseases

Search more.